Shares of Zydus Lifesciences were trading 3% higher on 7 November after the company announced its earnings for the July-September quarter of the current fiscal...
Indian Pharmaceutical major Zydus Lifesciences, on 31 October, announced that its board had approved the acquisition of LiqMeds for Rs 689 crore. The company is...
Zydus Lifesciences shares were trading marginally above on 23 October after the company announced receiving approval from USFDA (the United States Food and Drug Administration)...
Zydus Lifesciences Limited on 6 October announced that it had received the final approval from the USFDA (the United States Food and Drug Administration) for...
Zydus Lifesciences on 21 September announced that it had received final approval from the USFDA (United States Food and Drug Administration) for a skin-care gel...
Zydus Lifesciences has received final approval from the USFDA (United States Food and Drug Administration) to manufacture and market its Arthritis drug Indomethacin suppositories 50mg....
Zydus Animal Health and Investments Ltd (ZAHL), a wholly owned subsidiary of Zydus Lifesciences Ltd, has entered into share purchase agreements with Rising Sun Holdings...
From September 30, Adani Group‘s flagship entity, Adani Enterprises Ltd (AEL), will be included in the Nifty 50, the National Stock Exchange benchmark index, replacing...